Michelle L. Basil, EVP and General Counsel at HAEMONETICS CORP (HAE), sold 37,738 shares at $88.57 ($3.4M) on 2024-05-29, disclosed to the SEC on 2024-05-29.
Scheduled sale ($3.4M) by EVP and General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.73 | 11,758 | $1.1M | 33.0% |
| 2 | $87.86 | 8,896 | $782K | 22.9% |
| 3 | $87.86 | 8,896 | $782K | 22.9% |
| 4 | $88.57 | 4,094 | $363K | 10.6% |
| 5 | $88.57 | 4,094 | $363K | 10.6% |
| Total | $90.47 avg | 37,738 |
| $3.4M |
| 100% |
| Filing → |
| HAE | SELL | 2022-10-26 | $14K | — | Filing → |
| HAE | SELL | 2022-09-21 | $1.8M | — | Filing → |
| HAE | SELL | 2022-09-19 | $5.3M | — | Filing → |